Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Gyorki

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The British Journal of Dermatology|July 31, 2020
Extent of ulceration in cutaneous melanoma: is this biomarker ready for primetime?M J Wilkinson, D E Gyorki
The British Journal of Surgery|May 15, 2020
Providing cancer surgery in the COVID-19 crisisJ S Downs, M J Wilkinson, D E Gyorki, et al.
Annals of the Royal College of Surgeons of England|September 21, 2011
Management of synchronous tumours of the oesophagus and pancreatic head: a novel approachD E Gyorki, N E Clarke, M W Hii, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 11, 2017
Subungual melanoma: Management in the modern eraD J Reilly, G Aksakal, R F Gilmour, et al.
ANZ Journal of Surgery|June 26, 2010
Enterocutaneous fistula: a single-centre experienceD E Gyorki, C E Brooks, R Gett, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 5, 2021
Desmoplastic melanoma: a review of its pathology and clinical behaviour, and of management recommendations in published guidelinesT M Hughes, G J Williams, D E Gyorki, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 24, 2013
Incidence and location of positive nonsentinel lymph nodes in head and neck melanomaD E Gyorki, J O Boyle, I Ganly, et al.
Nature Medicine|October 5, 2021
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trialR Dummer, D E Gyorki, J Hyngstrom, et al.
Scientific Reports|July 26, 2018
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanomaH Halse, A J Colebatch, P Petrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2019
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNAL Tan, S Sandhu, R J Lee, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The British Journal of Dermatology|July 31, 2020
Extent of ulceration in cutaneous melanoma: is this biomarker ready for primetime?M J Wilkinson, D E Gyorki
The British Journal of Surgery|May 15, 2020
Providing cancer surgery in the COVID-19 crisisJ S Downs, M J Wilkinson, D E Gyorki, et al.
Annals of the Royal College of Surgeons of England|September 21, 2011
Management of synchronous tumours of the oesophagus and pancreatic head: a novel approachD E Gyorki, N E Clarke, M W Hii, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 11, 2017
Subungual melanoma: Management in the modern eraD J Reilly, G Aksakal, R F Gilmour, et al.
ANZ Journal of Surgery|June 26, 2010
Enterocutaneous fistula: a single-centre experienceD E Gyorki, C E Brooks, R Gett, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 5, 2021
Desmoplastic melanoma: a review of its pathology and clinical behaviour, and of management recommendations in published guidelinesT M Hughes, G J Williams, D E Gyorki, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 24, 2013
Incidence and location of positive nonsentinel lymph nodes in head and neck melanomaD E Gyorki, J O Boyle, I Ganly, et al.
Nature Medicine|October 5, 2021
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trialR Dummer, D E Gyorki, J Hyngstrom, et al.
Scientific Reports|July 26, 2018
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanomaH Halse, A J Colebatch, P Petrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2019
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNAL Tan, S Sandhu, R J Lee, et al.
Pageof 2